Whois & Analysis for celgene.com

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders.

It is incorporated in Delaware and headquartered in Summit, New Jersey.

The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients.

Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.

Revlimid is sold through proprietary risk-management distribution programs to ensure safe and appropriate use of these pharmaceuticals.

Vidaza is approved for the treatment of patients with MDS.

Hematology, also spelled haematology (from the Greek , haima "blood," and -λoγία), is the branch of medicine concerned with the study, diagnosis, treatment, and prevention of diseases related to blood.

Hematology includes the study of cause].

It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation.

Such diseases might include hemophilia, blood clots, other bleeding disorders and blood cancers such as leukemia, myeloma, and lymphoma.

The laboratory work that goes into the study of blood is frequently performed by a medical technologist or medical laboratory scientist.

Many hematologists work as hematologist-oncologists, also providing medical treatment for all types of cancer.

A biopharmaceutical, also known as a biologic(al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.

Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy.

Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues.

They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Immunology is a branch of biology that covers the study of immune systems in all organisms.

It was the Russian biologist Ilya Ilyich Mechnikov who boosted studies on immunology, and received the Nobel Prize in 1908 for his work.

He jabbed the thorn of a rose on a starfish and noted that, 24 hours later, cells were surrounding the tip.

It was an active response of the body, trying to maintain its integrity.

It was Mechnikov who first observed the phenomenon of phagocytosis, in which the body defends itself against a foreign body, and coined the term.

It charts, measures, and contextualizes the: physiological functioning of the immune system in states of both health and diseases; malfunctions of the immune system in immunological disorders (such as autoimmune diseases, hypersensitivities, immune deficiency, and transplant rejection); the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo.

Immunology has applications in numerous disciplines of medicine, particularly in the fields of organ transplantation, oncology, virology, bacteriology, parasitology, psychiatry, and dermatology.

Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.

A medical professional who practices oncology is an oncologist.

The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass".